Rare Disease Trial, Recruiting NCT06855901 Sponsor: Azienda Ospedaliero-Universitaria di Modena Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06855901
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 12 years old, with or without an intellectual disability
  • You have been diagnosed with seizures that have not responded well to medication, a difficult-to-control epilepsy condition, or a rare form of epilepsy
  • You have had one or more types of seizures in the past that have been identified and recorded, so doctors can recognize your specific seizure pattern
  • You are able to take part in the study for the full 3-month duration

Who may not be able to join:

  • You have been diagnosed with certain mental health conditions, such as schizophrenia, bipolar disorder, schizoaffective disorder, or emotionally unstable personality disorder
  • You have significant bone or skeletal problems at the area of the body where a small device would be placed, which could make correct placement impossible
  • You currently have an infection at the site where the device would be implanted
  • You are considered high risk for surgical complications, such as having an active widespread infection or a condition that affects blood clotting
  • You already use, or are regularly exposed to, a medical device that sends electrical signals near where the implant would go, such as a cochlear implant (a hearing device)
  • Your job or a hobby involves activities that could seriously damage the device or the implant site, such as martial arts or boxing
  • You have a known allergy or medical reason why you cannot receive local anaesthetic (numbing medication used during the procedure)
  • You are unable to operate the device yourself and do not have someone available to help you use it properly
  • You are currently pregnant

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stefano Meletti, MD, PhD, Azienda Ospedaliero Universitaria di Modena - Ospedale Civile di Baggiovara - S.S.D. Neurofisiologia

Phone: +390593961157

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliero-Universitaria di Modena
Registry
ClinicalTrials.gov
Start date
17 January 2024
Est. completion
31 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Assessment of the reportability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov